K191382 is an FDA 510(k) clearance for the IPS e.max CAD Abutment Solutions- extra systems. Classified as Abutment, Implant, Dental, Endosseous within the NHA classification (a category for dental implant abutments and prosthetic components), Class II - Special Controls.
Submitted by Ivoclar Vivadent, AG (Schaan, LI). The FDA issued a Cleared decision on August 26, 2019 after a review of 95 days - within the typical 510(k) review window.
This device falls under the Dental FDA review panel, regulated under 21 CFR 872.3630 - the FDA dental device regulatory framework. The Abbreviated 510(k) pathway was used, relying on FDA-recognized standards to demonstrate substantial equivalence.
Device pattern: Standards-based predicate clearance. Standards-verified equivalence. The Abbreviated pathway signals strong alignment with FDA-recognized performance standards - typically associated with lower review burden and faster clearance cycles.
View all Ivoclar Vivadent, AG devices